Expression profiling of circulating microvesicles reveals intercellular transmission of oncogenic pathways

Molecular Cancer Research

Volumn 15, Issue 6, 2017, Pages 683-695

  Milani, Gloria ^a,d   Lana, Tobia ^a   Bresolin, Silvia ^a   Aveic, Sanja ^b   Pastò, Anna ^c   Frasson, Chiara ^a,b   Te Kronnie, Geertruy ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Fondazione Istituto di Ricerca Pediatrica Città della Speranza   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TRANSCRIPTOME; BCR ABL PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; MLL-AF6 FUSION PROTEIN, HUMAN; ONCOPROTEIN; TEL-AML1 FUSION PROTEIN; TRANSCRIPTION FACTOR RUNX1; TUMOR MARKER;

ARTICLE; BCR ABL1 GENE; CELL COMMUNICATION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; COCULTURE; CONTROLLED STUDY; FUSION GENE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA; LEUKEMIA CELL; LEUKEMIA CELL LINE; LEUKEMOGENESIS; MEMBRANE MICROPARTICLE; MESENCHYMAL STEM CELL; MICROARRAY ANALYSIS; ONCOGENE; PRIORITY JOURNAL; CARCINOGENESIS; EXOSOME; GENETICS; K-562 CELL LINE; MESENCHYMAL STROMA CELL; PATHOLOGY; PHYSIOLOGY; PROCEDURES; SIGNAL TRANSDUCTION;

BIOMARKERS, TUMOR; CARCINOGENESIS; CELL PROLIFERATION; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EXTRACELLULAR VESICLES; FUSION PROTEINS, BCR-ABL; GENE EXPRESSION PROFILING; HUMANS; K562 CELLS; LEUKEMIA; MESENCHYMAL STROMAL CELLS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 85020396487     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-16-0307     Document Type: Article

References (47)

1. Turturici G, Tinnirello R, Sconzo G, Geraci F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol 2014;306:C621-33.
2. Revenfeld AL, Bæk R, Nielsen MH, Stensballe A, Varming K, Jørgensen M. Diagnostic and prognostic potential of extracellular vesicles in peripheral blood. Clin Ther 2014;36:830-46.
3. Camussi G, Deregibus MC, Bruno S, Grange C, Fonsato V, Tetta C. Exosome/microvesicle-mediated epigenetic reprogramming of cells. Am J Cancer Res 2011;1:98-110.
4. Yoon YJ, Kim OY, Gho YS. Extracellular vesicles as emerging intercellular communicasomes . BMB Rep 2014;47:531-9.
5. Christianson HC, Svensson KJ, Belting M.Exosome andmicrovesicle mediated phene transfer in mammalian cells. Semin Cancer Biol 2014;28:31-8.
6. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosomemediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654-9.
7. Deregibus MC, Cantaluppi V, Calogero R, Lo Iacono M, Tetta C, Biancone L, et al. Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007;110:2440-8.
8. Bruno S, Grange C, Deregibus MC, Calogero RA, Saviozzi S, Collino F, et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20:1053-67.
9. Ju GQ, Cheng J, Zhong L, Wu S, Zou XY, Zhang GY, et al. Microvesicles derived from human umbilical cord mesenchymal stem cells facilitate tubular epithelial cell dedifferentiation and growth via hepatocyte growth factor induction. PLoS One 2015;10: e0121534.
10. Ratajczak J, Miekus K, Kucia M, Zhang J, Reca R, Dvorak P, et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery. Leukemia 2006;20:847-56.
11. Lee Y, El Andaloussi S, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy.Hum Mol Genet 2012;21(R1):R125-34.
12. Sun Y, Liu J. Potential of cancer cell-derived exosomes in clinical application: a review of recent research advances. Clin Ther 2014;36:863-72.
13. Tetta C, Ghigo E, Silengo L, Deregibus MC, Camussi G. Extracellular vesicles as an emerging mechanism of cell-to-cell communication. Endocrine 2013;44:11-9.
14. Martins VR, Dias MS, Hainaut P. Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr Opin Oncol 2013;25: 66-75.
15. Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10:1470-6.
16. Hong BS, Cho JH, Kim H, Choi EJ, Rho S, Kim J, et al. Colorectal cancer cellderived microvesicles are enriched in cell cycle-related mRNAs that promote proliferation of endothelial cells. BMC Genomics 2009;10:556.
17. Renzulli JFII, Del Tatto M, DoonerG, Aliotta J, Goldstein L, DoonerM, et al. Microvesicle induction of prostate specific gene expression in normal human bone marrow cells. J Urol 2010;184:2165-71.
18. Del Tatto M, Ng T, Aliotta JM, Colvin GA, DoonerMS, Berz D, et al. Marrow cell genetic phenotype change induced by human lung cancer cells. Exp Hematol 2011;39:1072-80.
19. Grange C, Tapparo M, Collino F, Vitillo L, Damasco C, Deregibus MC, et al. Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res 2011;71:5346-56.
20. He M, Crow J, Roth M, Zeng Y, Godwin AK. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip 2014;14:3773-80.
21. Kahlert C, Melo SA, Protopopov A, Tang J, Seth S, Koch M, et al. Identification of double-stranded genomicDNAspanning all chromosomeswith mutated KRAS and p53 DNA in the serum exosomes of patients with pancreatic cancer. J Biol Chem 2014;289:3869-75.
22. Oishi Y, Watanabe Y, Yoshida Y, Sato Y, Hiraishi T, Oikawa R, et al. Hypermethylation of Sox17 gene is useful as a molecular diagnostic application in early gastric cancer. Tumour Biol 2012;33:383-93.
23. Korten S, Albet-Torres N, Paderi F, ten Siethoff L, Diez S, Korten T, et al. Sample solution constraints on motor-driven diagnostic nanodevices. Lab Chip 2013;13:866-76.
24. Kumar S, Milani G, Takatsuki H, Lana T, Persson M, Frasson C, et al. Sensing protein antigen andmicrovesicle analytes using high-capacity biopolymer nano-carriers. Analyst 2016;141:836-46.
25. Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, et al. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 2013; 119:1159-67
26. Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One 2010;5:e13247.
27. Van Dongen JJ, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 1999;13:1901-28.
28. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, et al. A census of human cancer genes. Nat Rev Cancer 2004;4:177-83.
29. Isserlin R, Merico D, Voisin V, Bader GD. Enrichment Map - a Cytoscape app to visualize and exploreOMICs pathway enrichment results. F1000Res 2014;3:141.
30. Milani G, Rebora P, Accordi B, Galla L, Bresolin S, Cazzaniga G, et al. Low PKCa expression within the MRD-HR stratum defines a new subgroup of childhood T-ALL with very poor outcome. Oncotarget 2014;5:5234-45.
31. Aveic S, Pantile M, Seydel A, Esposito MR, Zanon C, Gary Li, et al. Combating autophagy is a strategy to increase cytotoxic effects of novel ALK inhibitor entrectinib in neuroblastoma cells. Oncotarget 2016;7: 5646-63.
32. Orlovsky K, Kalinkovich A, Rozovskaia T, Shezen E, Itkin T, Alder H, et al. Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation. Proc Natl Acad Sci U S A 2011;108:7956-61.
33. Imamura T, Morimoto A, Takanashi M, Hibi S, Sugimoto T, Ishii E, et al. Frequent co-expression of HoxA9 and Meis1 genes in infant acute lymphoblastic leukaemia with MLL rearrangement. Br J Haematol 2002;119: 119-21.
34. Ayton PM, Cleary ML. Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9. Genes Dev 2003;17: 2298-307.
35. Wong P, Iwasaki M, Somervaille TC, So CW, Cleary ML. Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential. Genes Dev 2007;21:2762-74.
36. Faber J, Krivtsov AV, Stubbs MC, Wright R, Davis TN, van den Heuvel- EibrinkM, et al. HOXA9 is required for survival in human MLL-rearranged acute leukemias. Blood 2009;113:2375-85.
37. Zhu X, You Y, Li Q, Zeng C, Fu F, Guo A, et al. BCR-ABL1-positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia. Leukemia 2014; 28:1666-75.
38. Paderi F, Frasson C, Gelain S, Basso G, te Kronnie G. Specific circulating microvesicles (cMVs) populations in paediatric ALL. Blood 2011; 118:933.
39. Chen X, Xiong W, Li H. Comparison of microRNA expression profiles in K562-cells-derived microvesicles and parental cells, and analysis of their roles in leukemia. Oncol Lett 2016;12:4937-48.
40. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009;41:843-8.
41. Mongan NP, Martin KM, Gudas LJ. The putative human stem cell marker, Rex-1 (Zfp42): structural classification and expression in normal human epithelial and carcinoma cell cultures. Mol Carcinog 2006;45:887-900.
42. Son MY, Choi H, Han YM, Cho YS. Unveiling the critical role of REX1 in the regulation of human stem cell pluripotency. Stem Cells 2013;31: 2374-87.
43. Dillon LM, Bean JR, Yang W, Shee K, Symonds LK, Balko JM, et al. PREX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer. Oncogene 2015;34: 3968-76.
44. Lu L, Chen XM, Tao HM, Xiong W, Jie SH, Li HY. Regulation of the expression of zinc finger protein genes by microRNAs enriched within acute lymphoblastic leukemia-derived microvesicles. Genet Mol Res 2015;14:11884-95.
45. Kim HS, Choi DY, Yun SJ, Choi SM, Kang JW, Jung JW, et al. Proteomic analysis of microvesicles derived from human mesenchymal stem cells. J Proteome Res 2012;11:839-49.
46. Peinado H, Aleckovic M, Lavotshkin S, Matei I, Costa-Silva B, Moreno- Bueno G, et al. Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med 2012;18:883-91.
47. Razmkhah F, Soleimani M, Mehrabani D, Karimi MH, Kafi-Abad SA. Leukemia cell microvesicles promote survival in umbilical cord blood hematopoietic stem cells. EXCLI J 2015;14:423-9.